American College of Obstetricians and Gynecologists
An obstetrician and gynecologist with a private practice in Plano, TX, Dr. Keith Reisler completed his residency at the University of Texas Southwestern Medical School. Keith Reisler, MD, also serves as a fellow of the American College of Obstetricians and Gynecologists (ACOG).
Dedicated to improving women’s health throughout the world, ACOG was established in 1951. The nonprofit organization focuses on educational resources and programs, while its companion organization, the American Congress of Obstetricians and Gynecologists, focuses on advocacy, practice, and research. With nearly 60,000 members, ACOG is open to everyone in the field of women’s health, from medical students to allied educational affiliates.
ACOG membership is divided into categories based on specialty and experience. ACOG fellows are board-certified ob-gyns with current, unrestricted licenses to practice. Fellow membership applications and qualifications are reviewed by the organization’s executive board, a process that can take up to four months.
Dr Keith Reisler
An experienced obstetrician and gynecologist, Keith Reisler, MD, provides a high professional standard of care to women at his Plano, TX-based private practice. Among the many screening methods Dr. Keith Reisler relies on to keep women healthy, Pap smears allow doctors to detect signs of cervical cancer.
The Pap smear is a common diagnostic test that looks for tell-tale changes in vaginal and cervical cells. These changes may signal the presence of cancer or pre-cancerous conditions. Guidelines suggest that women get their first pap smear at age 21 and then undergo follow-up tests in 3 year intervals. However many doctors still recommend yearly Pap smears. Even if Pap smears are performed at less frequency intervals it is still recommended that patients are seen annually for a gynecological exam.
If cervical cancer, a type of cancer caused by the HPV virus, is detected in its early stages, doctors have a better chance of eliminating it before it can spread. According to the US Centers for Disease Control and Prevention, roughly 12,000 American women develop cervical cancer annually. Of those 12,000, about one-third end up dying from the disease.
Board certified by the American Board of Obstetrics and Gynecology, Keith Reisler, MD, has practiced medicine for over 30 years. Specializing in women’s health, Dr. Keith Reisler of Plano, TX, completed his Obstetrics and Gynecology residency training at the University of Texas Southwestern Medical School-Parkland Hospital, and is currently a private practitioner. He is trained in a minimally invasive procedure called hysteroscopy.
A hysteroscopy is a surgical procedure without an incision that allows a clinician to examine the interior of a patient’s uterus. With the use of glycine or normal saline, the uterus is filled and a lighted instrument called a hysteroscope is inserted into the uterus via the vagina and cervix. With minimal invasion, the procedure allows for a surgeon or gynecologist to view and perform medical treatments inside the uterus.
A hysteroscopy may be used to treat abnormal vaginal bleeding via surgical removal of damaged tissue or cauterization with an electric current or laser. Additionally, the procedure allows for a clinician to determine the cause of severe blood loss due to uterine fibroids. Another advantage of a hysteroscopy is the ability for a gynecologist to administer treatment involving medications with significant side effects based on a conclusive diagnosis.
Done on an outpatient basis, a hysteroscopy takes up to 45 minutes and requires either spinal or general anesthesia. In preparation for the procedure, patients are requested to fast and abstain from ingesting any solid food or liquid drinks for up to eight hours before the exam.
Dr Keith Reisler
Having received his medical degree from State University of New York, Downstate College of Medicine, Dr. Keith Reisler of Plano, TX, has practiced healthcare for over 30 years. Specializing in women’s health, Keith Reisler, MD, is board certified by the American Board of Obstetrics and Gynecology and currently a private practitioner. He is trained in a minimally invasive procedure to remove uterine fibroids with the use of a power morcellator.
Recent findings by the Journal of the American Medical Association – Oncology reports that when a small power tool called a morcellator is used to remove fibroids in the uterus, the likelihood of causing the spread of hidden cancerous tumors inside the abdomen is low. Although reassuring, the device remains under restricted use. In fact Dr. Keith Reisler was interviewed by the Wall Street Journal regarding this subject in an article published April, 2014. At that time Dr Reisler cautioned against the use of this instrument until more studies were available.
The power morcellator uses a rotating blade, allowing a surgeon to break apart uterine fibroids or the uterus itself during a hysterectomy. After the tissue has been morcellated, the remains may be removed via tiny incisions.
While the Food and Drug Administration (FDA) cautioned clinicians not to use the power morcellator in removing uterine fibroids on most females due to the risk of having undiagnosed cancerous uterine tumors, the FDA states some younger females may still be adequate candidates for use with the device. Chief of gynecologic oncology, Dr. Jason Wright at Columbia University examined over 42,000 cases of females in the United States between 2012 and 2016 who had uterine fibroids removed. Of that, only three females developed uterine cancer from more than 3,200 power morcellator procedures. Dr Keith Reisler still cautions against the use of this instrument in most patients since there is also concern about the spread of endometriosis and fibroid tumors throughout the abdominal cavity with the use of this instrument.
Keith Reisler, MD, provides high-quality obstetric and gynecological care at his private office in Plano, TX. There, Dr. Keith Reisler has welcomed numerous women with pregnancies classified as high-risk.
The term high-risk can be intimidating, particularly when applied to a pregnancy. It does not mean, however, that there is certainly or almost certainly something wrong with the baby. It simply means that the mother or baby is more likely than average to present with challenges during gestation or delivery. This can be true of any pregnant woman who is below the age of 17 or above the age of 35, is expecting multiple babies, or has experienced two or more spontaneous pregnancy losses.
Mothers with a history of previous labor and delivery problems, or who have children with genetic abnormalities, also receive the attention due to a high-risk pregnancy. The same is true for women whose current prenatal care has identified a genetic condition in the developing fetus.
An expectant mother may also be at high risk if she has certain medical issues of her own, hypertension and diabetes being prominent examples. Cardiovascular issues, history of kidney infections, history of seizures, autoimmune disease, and other chronic illnesses can similarly increase risk, as can some medications. Women who believe that they may be at high risk should consult with their obstetrician for further information.
Dr Keith Reisler
As a privately practicing obstetrician and gynecologist, Dr. Keith Reisler, of Plano, TX, has treated numerous cases of fibroid tumors. Keith Reisler, MD, focuses on the use of hysteroscopic resection of such tumors, so as to minimize the need for additional or more intensive treatment.
Hysteroscopic fibroid resection, also known as transcervical resection of fibroids (TCRF), uses a specially designed surgical instrument to remove growths in the uterus. The procedure uses a thin scope that can pass easily through the vagina and cervix and into the uterus, where a telescopic end enables the surgeon to view the growth. A resectoscope, which includes a wire loop and electrical current, then allows the surgeon to cut away the fibroid and draw it out through the vagina.
Performed under general anesthesia, the procedure is typically done on an outpatient basis. The operation itself lasts for approximately 60 minutes, while postoperative recovery phase can last up to 2 hours. The patient then returns home for an additional one to two days of recovery. The process can be ideal for patients with fibroids that grow from the inner lining into the uterine cavity, though those that are deeper in the uterine wall may be difficult to reach by endoscope.